1. Home
  2. TLSA vs BYND Comparison

TLSA vs BYND Comparison

Compare TLSA & BYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • BYND
  • Stock Information
  • Founded
  • TLSA 2013
  • BYND 2009
  • Country
  • TLSA United Kingdom
  • BYND United States
  • Employees
  • TLSA N/A
  • BYND N/A
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • BYND Packaged Foods
  • Sector
  • TLSA Health Care
  • BYND Consumer Staples
  • Exchange
  • TLSA Nasdaq
  • BYND Nasdaq
  • Market Cap
  • TLSA 187.0M
  • BYND 183.2M
  • IPO Year
  • TLSA 2000
  • BYND 2019
  • Fundamental
  • Price
  • TLSA $1.66
  • BYND $2.46
  • Analyst Decision
  • TLSA
  • BYND Sell
  • Analyst Count
  • TLSA 0
  • BYND 4
  • Target Price
  • TLSA N/A
  • BYND $3.67
  • AVG Volume (30 Days)
  • TLSA 369.4K
  • BYND 2.2M
  • Earning Date
  • TLSA 05-06-2025
  • BYND 11-05-2025
  • Dividend Yield
  • TLSA N/A
  • BYND N/A
  • EPS Growth
  • TLSA N/A
  • BYND N/A
  • EPS
  • TLSA N/A
  • BYND N/A
  • Revenue
  • TLSA N/A
  • BYND $301,353,000.00
  • Revenue This Year
  • TLSA N/A
  • BYND N/A
  • Revenue Next Year
  • TLSA N/A
  • BYND $0.73
  • P/E Ratio
  • TLSA N/A
  • BYND N/A
  • Revenue Growth
  • TLSA N/A
  • BYND N/A
  • 52 Week Low
  • TLSA $0.63
  • BYND $2.23
  • 52 Week High
  • TLSA $2.60
  • BYND $7.60
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 40.76
  • BYND 40.69
  • Support Level
  • TLSA $1.73
  • BYND $2.29
  • Resistance Level
  • TLSA $1.90
  • BYND $2.70
  • Average True Range (ATR)
  • TLSA 0.15
  • BYND 0.13
  • MACD
  • TLSA -0.05
  • BYND 0.02
  • Stochastic Oscillator
  • TLSA 24.19
  • BYND 41.46

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

Share on Social Networks: